Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy

NCT00485953 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Bone Loss
Osteoporosis
Breast Cancer

Interventions

DRUG: risedronate

Sponsor

Susan L. Greenspan

Collaborators

[object Object]